Categories: AnalyticsDataDatabaseDiagnosticsDrugHealthTechManagementOptimizePlatformProduct
Cellular liquid biopsy yields earlier, precise answers for better therapeutics
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.07.2024 | Seed | $5.2M | - |
Mentions in press and media 6
| Date | Title | Description |
| 02.10.2025 | Predicta Biosciences Raises $23.4M in Series A Funding | Predicta Biosciences, a Cambridge, MA-based precision oncology company developing novel diagnostic and therapeutic discovery solutions, raised $23.4m in Series A funding.
The round was led by Engine Ventures with particiaption from Illumina... |
| 29.07.2024 | Predicta Biosciences: Pioneering a New Era in Cancer Diagnostics | Predicta Biosciences is making waves in the ocean of cancer diagnostics. With a fresh infusion of $5.2 million in seed funding, this Boston-based precision oncology company is poised to change the landscape of how we detect and treat blood ... |
| 27.07.2024 | Predicta Biosciences Raises $5.2 Million To Develop Novel Diagnostic And Therapeutic Products | Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic products, announced it had raised an oversubscribed $5.2 million seed round led by The Engine Ventures. And additional participating investors in... |
| 16.07.2024 | Predicta Biosciences Raises $5.2M in Seed Funding | Predicta Biosciences team (Photo: Business Wire)
Predicta Biosciences, a Boston, MA-based precision oncology company developing diagnostic and therapeutic products, raised $5.2M in Seed funding.
The round was led by The Engine Ventures, wit... |
| - | Predicta Biosciences | “Home | Predicta Biosciences” |
| - | Predicta Biosciences | “Unlocking Precision Therapeutics With Transformative Diagnostics” |
Reviews 0
